Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Seattle Genetics Company Profile (NASDAQ:SGEN)

Consensus Ratings for Seattle Genetics (NASDAQ:SGEN) (?)
Ratings Breakdown: 2 Sell Rating(s), 2 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $44.30 (25.67% upside)

Current Analysts' Coverage Summary for Seattle Genetics (NASDAQ:SGEN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
9/30/2014Bank of AmericaDowngradeNeutral -> Underperform$40.00 -> $34.00ViewTweet This Rating  Share This Rating on StockTwits
8/19/2014ZacksDowngradeOutperform -> Neutral$46.10ViewTweet This Rating  Share This Rating on StockTwits
5/2/2014Cantor FitzgeraldBoost Price Target$24.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
5/2/2014Jefferies GroupReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
4/28/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/10/2014HC WainwrightInitiated CoverageBuy$65.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Credit SuisseBoost Price Target$46.00 -> $51.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014GuggenheimBoost Price Target$33.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
2/12/2014Needham & Company LLCUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
12/20/2013RBC CapitalBoost Price Target$44.00 -> $48.00ViewTweet This Rating  Share This Rating on StockTwits
12/9/2013Piper JaffrayReiterated RatingUnderweightViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Goldman SachsBoost Price Target$37.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
8/5/2013Leerink SwannBoost Price Target$42.00 -> $53.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/20/2012 forward)
Discuss Seattle Genetics